ARTICLE | Company News
AMEV, Lilly optimization deal
December 19, 2001 8:00 AM UTC
Applied Molecular Evolution (AMEV) will use its AMEsystem directed molecular evolution technology to optimize 1 antibody and 1 non-antibody protein therapeutic for LLY. AMEV will receive an upfront si...